ABCD Mnemonic in moderate to severe COVID-19 management

被引:0
|
作者
Ahuja, Vanita [1 ]
Mahajan, Aastika [1 ]
Bevoor, Arun A. [1 ]
机构
[1] Govt Med Coll & Hosp, Dept Anaesthesia & Intens Care, Chandigarh 160047, India
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:153 / 154
页数:2
相关论文
共 50 条
  • [1] ABCD Mnemonic in moderate to severe COVID-19 management
    Ahuja, Vanita
    Mahajan, Aastika
    Bevoor, Arun A.
    [J]. JOURNAL OF ANAESTHESIOLOGY CLINICAL PHARMACOLOGY, 2022, 38 : 153 - 154
  • [2] Adrenomedullin Therapy in Moderate to Severe COVID-19
    Kita, Toshihiro
    Kitamura, Kazuo
    [J]. BIOMEDICINES, 2022, 10 (03)
  • [3] Intrapartum Management of Moderate to Severe COVID-19: an Evidence-Based Update
    Kelly Albrecht
    Mary Catherine Tolcher
    [J]. Current Obstetrics and Gynecology Reports, 2023, 12 (3) : 165 - 172
  • [4] Transfusion Support for Moderate and Severe Cases of COVID-19
    Walker, L.
    Wickenheiser, Z.
    [J]. TRANSFUSION, 2023, 63 : 317A - 318A
  • [5] Residual symptoms in moderate to severe COVID-19 patients
    Elfidha, Sabrine
    Louhaichi, Sabrine
    Khalfallah, Ikbel
    Marzouki, Safa
    Kaabi, Line
    Jebeli, Rihab
    Kharrat, Mohamed Ali
    Ammar, Jamel
    Hamdi, Besma
    Hamzaoui, Agnes
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [6] The effect of Fingolimod on patients with moderate to severe COVID-19
    Teymouri, Soheil
    Kaleybar, Siamak Pourbayram
    Hejazian, Seyyed Sina
    Hejazian, Seyyedeh Mina
    Ansarin, Khalil
    Ardalan, Mohammadreza
    Vahed, Sepideh Zununi
    [J]. PHARMACOLOGY RESEARCH & PERSPECTIVES, 2023, 11 (01):
  • [7] Remdesivir treatment for patients with moderate to severe COVID-19
    Hasanoglu, Imran
    Guner, Rahmet
    Celik, Ilhami
    Kanat, Fikret
    Batirel, Ayse
    Dizman, Gulcin Telli
    Eren, Esma
    Sevgi, Dilek Yildiz
    Bozkurt, Ilkay
    Yasar, Kadriye Kart
    Senoglu, Sevtap
    Kazak, Esra
    Karaali, Ridvan
    Celikbas, Aysel
    Pullukcu, Husnu
    Cagatay, Arif Atahan
    Unal, Serhat
    Erdinc, Sebnem
    Tabak, Fehmi
    Gul, Ahmet
    Alp, Emine
    [J]. TURKISH JOURNAL OF MEDICAL SCIENCES, 2022, 52 (04) : 880 - 887
  • [8] Infliximab Concentrations in Participants with Moderate to Severe COVID-19
    Balevic, Stephen J.
    Dandachi, Dima
    Dixon, Danielle
    Hoetelmans, Richard M. W.
    Bozzette, Sam
    Mccarthy, Matthew W.
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2024, 64 (04): : 490 - 491
  • [9] Remdesivir in moderate to severe COVID-19: A matter of time?
    Bonazzetti, Cecilia
    Giacomelli, Andrea
    Pavia, Martina
    Fusetti, Chiara
    Gerbi, Martina
    Petri, Francesco
    Poloni, Andrea
    Oreni, Letizia
    Ridolfo, Anna Lisa
    Antinori, Spinello
    [J]. PHARMACOLOGICAL RESEARCH, 2021, 170
  • [10] The use of remdesivir for the management of patients with moderate-to-severe COVID-19: a systematic review
    Thiruchelvam, Kaeshaelya
    Kow, Chia Siang
    Hadi, Muhammad Abdul
    Hasan, Syed Shahzad
    [J]. EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2022, 20 (02) : 211 - 229